glp 1 program Medicare Bridge Explained: GLP-1 Medications for Weight Loss We offer more than just

Several guidelines currently recommend GLP-1 RAs as add-on therapy to almost all diabetic treatments (with the exception of dipeptidyl peptidase-4 [DPP-4] inhibitors) and even as monotherapy to those intolerant to metformin

For reasons that still aren't understood, the same drug works far better for some people than for others

The information presented here is based on published clinical trial data and may not reflect the final approved prescribing information when and if FDA approval occurs.

Accessed 13 Feb 2017

The 2% of adults now taking GLP-1s specifically for an overweight or obesity diagnosis represents a 587% increase over the last five years

Q., Li L., et al